The transition from relapsing-remitting MS to irreversible disability: Clinical evaluation

Neurological Sciences

Volumn 24, Issue SUPPL. 5, 2003, Pages

  Trojano, M ^a   Paolicelli, D ^a   Bellacosa, A ^a   Cataldo, S ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Age; Disability progression; Disease duration; Multiple sclerosis; Prognosis

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA INTERFERON; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT;

AGE DISTRIBUTION; CLINICAL OBSERVATION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DISABILITY; DISEASE COURSE; DRUG RESPONSE; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATORY DISEASE; KAPLAN MEIER METHOD; MULTIPLE SCLEROSIS; PHENOTYPIC VARIATION; PROGNOSIS; RATING SCALE; REVIEW; SCORING SYSTEM;

ADULT; AGE FACTORS; CLINICAL TRIALS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 0345602745     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0171-6     Document Type: Review

References (15)

1. Morrissey SP, Miller DH, Kendall BE et al (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116:135-146
2. Weinshenker BG, Bass B, Rice GP et al (1989) The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain 112:133-146
3. Confavreux C, Aimard G Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103:281-300
4. Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430-1438
5. Trojano M, Avolio C, Manzari C et al (1995) Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 58:300-306
6. Runmarker B, Andersson C, Oden A, Andersen O (1994) Prediction of outcome in multiple sclerosis based on multivariate models. J Neurol 241:597-604
7. Ebers G (1998) Natural history of multiple sclerosis. In: Compston A, Ebers G, Lassman H, McDonald WI, Matthews B, Wekerle H (eds) McAlpine's multiple sclerosis, 3rd edn. Churchill Livingstone, London, pp 191-221
8. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M et al (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158-164
9. Trojano M, Liguori M, Zimatore GB (2002) Age-related disability in multiple sclerosis. Ann Neurol 51:475-480
10. Confavreux C, Vukusic S, Patrice A (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770-782
11. Bjartmar C, Yin X, Trapp BD (1999) Axonal pathology in myelin disorders. J Neurocytol 28:383-395
12. Scherer S (1999) Axonal pathology in demyelinating diseases. Ann Neurol 45:6-7
13. Revesz T, Kidd D, Thompson AJ et al (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117:759-765
14. Ebers GC, Koopman WJ, Hader W et al (2000) The natural history of multiple sclerosis: a geographically based study. 8. Familial multiple sclerosis. Brain 123:641-649
15. Thompson AJ, Hutchinson M, Brazil J et al (1986) A clinical and laboratory study of benign multiple sclerosis. Q J Med 58:69-80